FEDERAL · 42 U.S.C. · Chapter 7
Reporting of information relating to drug samples
42 U.S.C. § 1320a–7i
Title42 — The Public Health and Welfare
Chapter7 — SOCIAL SECURITY
SubchapterXI
PartA
Current throughPub. L. 119-99
This text of 42 U.S.C. § 1320a–7i (Reporting of information relating to drug samples) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
42 U.S.C. § 1320a–7i.
Text
(a)In general
Not later than April 1 of each year (beginning with 2012), each manufacturer and authorized distributor of record of an applicable drug shall submit to the Secretary (in a form and manner specified by the Secretary) the following information with respect to the preceding year:
(1)In the case of a manufacturer or authorized distributor of record which makes distributions by mail or common carrier under subsection (d)(2) of section 353 of title 21, the identity and quantity of drug samples requested and the identity and quantity of drug samples distributed under such subsection during that year, aggregated by—
(A)the name, address, professional designation, and signature of the practitioner making the request under subparagraph (A)(i) of such subsection, or of any individual
Free access — add to your briefcase to read the full text and ask questions with AI
Related
§ 353
21 U.S.C. § 353
Source Credit
History
(Aug. 14, 1935, ch. 531, title XI, §1128H, as added Pub. L. 111–148, title VI, §6004, Mar. 23, 2010, 124 Stat. 697.)
Cite This Page — Counsel Stack
Bluebook (online)
42 U.S.C. § 1320a–7i, Counsel Stack Legal Research, https://law.counselstack.com/usc/42/1320a–7i.